Liu Zhao, Zhang Yepeng, Liu Chen, Huang Dian, Zhang Ming, Ran Feng, Wang Wei, Shang Tao, Qiao Tong, Zhou Min, Liu Changjian
1 Department of Vascular Surgery, The Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
2 Southeast University Medical School, Nanjing, China.
J Int Med Res. 2017 Oct;45(5):1574-1584. doi: 10.1177/0300060517708893. Epub 2017 Jul 12.
Objective This study aimed to describe treatment of serious complications after primary thoracic endovascular aortic repair (TEVAR) in type B aortic dissection. Methods From June 2008 to March 2016, serious complications occurred in 58 patients without Marfan syndrome who received TEVAR for type B aortic dissection. Results Complications included endoleak, distal true lumen collapse, retrograde dissection, stroke, stent-graft (SG) migration and mistaken deployment, lower limb ischaemia, and SG fracture. Treatment included endovascular repair, surgical procedures, or conservative medication. Forty-six patients recovered from complications. Twelve patients were not cured. The median follow-up time was 29.5 months (2-61 months). The overall 30-day mortality rate was 1.7% (1/58) and the total mortality rate following secondary complications was 8.6% (5/58). The causes of death were stroke and aortic rupture. Conclusion Some treatments need to be performed after TEVAR because of severe complications. A reduction in these complications can be achieved by optimal evaluation of patients, selection of SGs, and specialized endovascular manipulation.
目的 本研究旨在描述B型主动脉夹层原发性胸主动脉腔内修复术(TEVAR)后严重并发症的治疗情况。方法 2008年6月至2016年3月,58例无马方综合征的B型主动脉夹层患者接受了TEVAR治疗,出现了严重并发症。结果 并发症包括内漏、远端真腔塌陷、逆行夹层、卒中、支架移植物(SG)移位和误置入、下肢缺血以及SG断裂。治疗包括血管腔内修复、外科手术或保守药物治疗。46例患者并发症治愈。12例患者未治愈。中位随访时间为29.5个月(2 - 61个月)。30天总死亡率为1.7%(1/58),继发并发症后的总死亡率为8.6%(5/58)。死亡原因是卒中和主动脉破裂。结论 由于严重并发症,TEVAR术后需要进行一些治疗。通过对患者的最佳评估、SGs的选择和专业的血管腔内操作,可以减少这些并发症。